A client taking clozapine calls the clinic and reports fever, chills, and a sore throat. The next dose is due soon. Which instruction should the nurse provide?

Fever, chills, and sore throat may indicate infection from clozapine-associated severe neutropenia. The client needs prompt clinical assessment and ANC evaluation before another dose. Current FDA guidance no longer requires REMS enrollment, but neutropenia monitoring remains important.

Quick answer
Hold the upcoming dose and arrange prompt evaluation for infection and neutropenia. Fever, chills, and sore throat are warning symptoms that require assessment before continued clozapine exposure.

Why this is correct
Clozapine can markedly lower neutrophils and reduce the body's ability to fight infection. Symptoms may appear before the client knows the blood count is low, so clinical evaluation and an ANC help guide whether treatment is paused, modified, or safely continued.

Easy analogy or mental picture
Neutrophils are like the first-response crew for infection. Clozapine can shrink that crew, so fever is an alarm that requires a head count; the analogy does not mean every fever is caused by neutropenia.

Memory hook
Clozapine plus infection symptoms means pause the next dose and check the infection-fighting cells.

NCLEX decision rule
For medications that can suppress bone marrow, connect fever, chills, sore throat, mouth ulcers, or unusual weakness with possible neutropenia. Hold the immediate dose and obtain timely clinical and laboratory guidance rather than masking symptoms.

Why the other choices are wrong
Acetaminophen can hide fever while serious infection progresses. Doubling clozapine has no therapeutic basis and increases toxicity, while permanent discontinuation without evaluation can cause relapse and ignores the individualized ANC-based plan.